#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Ventral striatal dysfunction in cocaine dependence – difference mapping for subregional resting state functional connectivity Research of dopaminergic deficits has focused on the ventral striatum (VS) with many studies elucidating altered resting state functional connectivity (rsFC) in individuals with cocaine dependence (CD).
1-1	0-7	Ventral	_
1-2	8-16	striatal	_
1-3	17-28	dysfunction	_
1-4	29-31	in	_
1-5	32-39	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
1-6	40-50	dependence	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
1-7	51-52	–	_
1-8	53-63	difference	_
1-9	64-71	mapping	_
1-10	72-75	for	_
1-11	76-87	subregional	_
1-12	88-95	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-13	96-101	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-14	102-112	functional	_
1-15	113-125	connectivity	_
1-16	126-134	Research	_
1-17	135-137	of	_
1-18	138-150	dopaminergic	_
1-19	151-159	deficits	_
1-20	160-163	has	_
1-21	164-171	focused	_
1-22	172-174	on	_
1-23	175-178	the	_
1-24	179-186	ventral	_
1-25	187-195	striatum	_
1-26	196-197	(	_
1-27	198-200	VS	_
1-28	201-202	)	_
1-29	203-207	with	_
1-30	208-212	many	_
1-31	213-220	studies	_
1-32	221-232	elucidating	_
1-33	233-240	altered	_
1-34	241-248	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-35	249-254	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-36	255-265	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-37	266-278	connectivity	_
1-38	279-280	(	_
1-39	281-285	rsFC	_
1-40	286-287	)	_
1-41	288-290	in	_
1-42	291-302	individuals	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
1-43	303-307	with	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
1-44	308-315	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
1-45	316-326	dependence	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
1-46	327-328	(	_
1-47	329-331	CD	_
1-48	332-333	)	_
1-49	334-335	.	_

Text=The VS comprises functional subregions and delineation of subregional changes in rsFC requires careful consideration of the differences between addicted and healthy populations.
2-1	336-339	The	_
2-2	340-342	VS	_
2-3	343-352	comprises	_
2-4	353-363	functional	_
2-5	364-374	subregions	_
2-6	375-378	and	_
2-7	379-390	delineation	_
2-8	391-393	of	_
2-9	394-405	subregional	_
2-10	406-413	changes	_
2-11	414-416	in	_
2-12	417-421	rsFC	_
2-13	422-430	requires	_
2-14	431-438	careful	_
2-15	439-452	consideration	_
2-16	453-455	of	_
2-17	456-459	the	_
2-18	460-471	differences	_
2-19	472-479	between	_
2-20	480-488	addicted	_
2-21	489-492	and	_
2-22	493-500	healthy	_
2-23	501-512	populations	_
2-24	513-514	.	_

Text=In the current study, we parcellated the VS using whole-brain rsFC differences between CD and non-drug-using controls (HC).
3-1	515-517	In	_
3-2	518-521	the	_
3-3	522-529	current	_
3-4	530-535	study	_
3-5	536-537	,	_
3-6	538-540	we	_
3-7	541-552	parcellated	_
3-8	553-556	the	_
3-9	557-559	VS	_
3-10	560-565	using	_
3-11	566-577	whole-brain	_
3-12	578-582	rsFC	_
3-13	583-594	differences	_
3-14	595-602	between	_
3-15	603-605	CD	_
3-16	606-609	and	_
3-17	610-624	non-drug-using	_
3-18	625-633	controls	_
3-19	634-635	(	_
3-20	636-638	HC	_
3-21	639-640	)	_
3-22	641-642	.	_

Text=Voxels with similar rsFC changes formed functional clusters.
4-1	643-649	Voxels	_
4-2	650-654	with	_
4-3	655-662	similar	_
4-4	663-667	rsFC	_
4-5	668-675	changes	_
4-6	676-682	formed	_
4-7	683-693	functional	_
4-8	694-702	clusters	_
4-9	703-704	.	_

Text=The results showed that the VS was divided into 3 subclusters, in the area of the dorsal-anterior VS (daVS), dorsal posterior VS (dpVS), and ventral VS (vVS), each in association with different patterns of rsFC.
5-1	705-708	The	_
5-2	709-716	results	_
5-3	717-723	showed	_
5-4	724-728	that	_
5-5	729-732	the	_
5-6	733-735	VS	_
5-7	736-739	was	_
5-8	740-747	divided	_
5-9	748-752	into	_
5-10	753-754	3	_
5-11	755-766	subclusters	_
5-12	767-768	,	_
5-13	769-771	in	_
5-14	772-775	the	_
5-15	776-780	area	_
5-16	781-783	of	_
5-17	784-787	the	_
5-18	788-803	dorsal-anterior	_
5-19	804-806	VS	_
5-20	807-808	(	_
5-21	809-813	daVS	_
5-22	814-815	)	_
5-23	816-817	,	_
5-24	818-824	dorsal	_
5-25	825-834	posterior	_
5-26	835-837	VS	_
5-27	838-839	(	_
5-28	840-844	dpVS	_
5-29	845-846	)	_
5-30	847-848	,	_
5-31	849-852	and	_
5-32	853-860	ventral	_
5-33	861-863	VS	_
5-34	864-865	(	_
5-35	866-869	vVS	_
5-36	870-871	)	_
5-37	872-873	,	_
5-38	874-878	each	_
5-39	879-881	in	_
5-40	882-893	association	_
5-41	894-898	with	_
5-42	899-908	different	_
5-43	909-917	patterns	_
5-44	918-920	of	_
5-45	921-925	rsFC	_
5-46	926-927	.	_

Text=The three subregions shared reduced rsFC with bilateral hippocampal/parahippocampal gyri (HG/PHG) but also showed distinct changes, including reduced vVS rsFC with ventromedial prefrontal cortex (vmPFC) and increased daVS rsFC with visual cortex in CD as compared to HC.
6-1	928-931	The	_
6-2	932-937	three	_
6-3	938-948	subregions	_
6-4	949-955	shared	_
6-5	956-963	reduced	_
6-6	964-968	rsFC	_
6-7	969-973	with	_
6-8	974-983	bilateral	_
6-9	984-1011	hippocampal/parahippocampal	_
6-10	1012-1016	gyri	_
6-11	1017-1018	(	_
6-12	1019-1025	HG/PHG	_
6-13	1026-1027	)	_
6-14	1028-1031	but	_
6-15	1032-1036	also	_
6-16	1037-1043	showed	_
6-17	1044-1052	distinct	_
6-18	1053-1060	changes	_
6-19	1061-1062	,	_
6-20	1063-1072	including	_
6-21	1073-1080	reduced	_
6-22	1081-1084	vVS	_
6-23	1085-1089	rsFC	_
6-24	1090-1094	with	_
6-25	1095-1107	ventromedial	_
6-26	1108-1118	prefrontal	_
6-27	1119-1125	cortex	_
6-28	1126-1127	(	_
6-29	1128-1133	vmPFC	_
6-30	1134-1135	)	_
6-31	1136-1139	and	_
6-32	1140-1149	increased	_
6-33	1150-1154	daVS	_
6-34	1155-1159	rsFC	_
6-35	1160-1164	with	_
6-36	1165-1171	visual	_
6-37	1172-1178	cortex	_
6-38	1179-1181	in	_
6-39	1182-1184	CD	_
6-40	1185-1187	as	_
6-41	1188-1196	compared	_
6-42	1197-1199	to	_
6-43	1200-1202	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
6-44	1203-1204	.	_

Text=Across CD, daVS visual cortical connectivity was positively correlated with amount of prior-month cocaine use and cocaine craving, and vVS vmPFC connectivity was negatively correlated with the extent of depression and anxiety.
7-1	1205-1211	Across	_
7-2	1212-1214	CD	_
7-3	1215-1216	,	_
7-4	1217-1221	daVS	_
7-5	1222-1228	visual	_
7-6	1229-1237	cortical	_
7-7	1238-1250	connectivity	_
7-8	1251-1254	was	_
7-9	1255-1265	positively	_
7-10	1266-1276	correlated	_
7-11	1277-1281	with	_
7-12	1282-1288	amount	_
7-13	1289-1291	of	_
7-14	1292-1303	prior-month	_
7-15	1304-1311	cocaine	_
7-16	1312-1315	use	_
7-17	1316-1319	and	_
7-18	1320-1327	cocaine	_
7-19	1328-1335	craving	_
7-20	1336-1337	,	_
7-21	1338-1341	and	_
7-22	1342-1345	vVS	_
7-23	1346-1351	vmPFC	_
7-24	1352-1364	connectivity	_
7-25	1365-1368	was	_
7-26	1369-1379	negatively	_
7-27	1380-1390	correlated	_
7-28	1391-1395	with	_
7-29	1396-1399	the	_
7-30	1400-1406	extent	_
7-31	1407-1409	of	_
7-32	1410-1420	depression	_
7-33	1421-1424	and	_
7-34	1425-1432	anxiety	_
7-35	1433-1434	.	_

Text=These findings suggest a distinct pattern of altered VS subregional rsFC in cocaine dependence, and some of the changes have eluded analyses using the whole VS as a seed region.
8-1	1435-1440	These	_
8-2	1441-1449	findings	_
8-3	1450-1457	suggest	_
8-4	1458-1459	a	_
8-5	1460-1468	distinct	_
8-6	1469-1476	pattern	_
8-7	1477-1479	of	_
8-8	1480-1487	altered	_
8-9	1488-1490	VS	_
8-10	1491-1502	subregional	_
8-11	1503-1507	rsFC	_
8-12	1508-1510	in	_
8-13	1511-1518	cocaine	_
8-14	1519-1529	dependence	_
8-15	1530-1531	,	_
8-16	1532-1535	and	_
8-17	1536-1540	some	_
8-18	1541-1543	of	_
8-19	1544-1547	the	_
8-20	1548-1555	changes	_
8-21	1556-1560	have	_
8-22	1561-1567	eluded	_
8-23	1568-1576	analyses	_
8-24	1577-1582	using	_
8-25	1583-1586	the	_
8-26	1587-1592	whole	_
8-27	1593-1595	VS	_
8-28	1596-1598	as	_
8-29	1599-1600	a	_
8-30	1601-1605	seed	_
8-31	1606-1612	region	_
8-32	1613-1614	.	_

Text=The findings may provide new insight to delineating VS circuit deficits in cocaine dependence and provide an alternative analytical framework to address functional dysconnectivity in other mental illnesses.
9-1	1615-1618	The	_
9-2	1619-1627	findings	_
9-3	1628-1631	may	_
9-4	1632-1639	provide	_
9-5	1640-1643	new	_
9-6	1644-1651	insight	_
9-7	1652-1654	to	_
9-8	1655-1666	delineating	_
9-9	1667-1669	VS	_
9-10	1670-1677	circuit	_
9-11	1678-1686	deficits	_
9-12	1687-1689	in	_
9-13	1690-1697	cocaine	_
9-14	1698-1708	dependence	_
9-15	1709-1712	and	_
9-16	1713-1720	provide	_
9-17	1721-1723	an	_
9-18	1724-1735	alternative	_
9-19	1736-1746	analytical	_
9-20	1747-1756	framework	_
9-21	1757-1759	to	_
9-22	1760-1767	address	_
9-23	1768-1778	functional	_
9-24	1779-1794	dysconnectivity	_
9-25	1795-1797	in	_
9-26	1798-1803	other	_
9-27	1804-1810	mental	_
9-28	1811-1820	illnesses	_
9-29	1821-1822	.	_

Text=Materials and methods Subjects, informed consent, and assessment Sixty-six recently abstinent participants (44 men) with cocaine dependence (CD) and 66 age- and gender-matched healthy control (HC) subjects (36 men) participated in the study (Supplementary Table 1).
10-1	1823-1832	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
10-2	1833-1836	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
10-3	1837-1844	methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
10-4	1845-1853	Subjects	_
10-5	1854-1855	,	_
10-6	1856-1864	informed	_
10-7	1865-1872	consent	_
10-8	1873-1874	,	_
10-9	1875-1878	and	_
10-10	1879-1889	assessment	_
10-11	1890-1899	Sixty-six	_
10-12	1900-1908	recently	_
10-13	1909-1918	abstinent	_
10-14	1919-1931	participants	_
10-15	1932-1933	(	_
10-16	1934-1936	44	_
10-17	1937-1940	men	_
10-18	1941-1942	)	_
10-19	1943-1947	with	http://maven.renci.org/NeuroBridge/neurobridge#AmphetamineDependence
10-20	1948-1955	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#AmphetamineDependence
10-21	1956-1966	dependence	http://maven.renci.org/NeuroBridge/neurobridge#AmphetamineDependence
10-22	1967-1968	(	http://maven.renci.org/NeuroBridge/neurobridge#AmphetamineDependence
10-23	1969-1971	CD	http://maven.renci.org/NeuroBridge/neurobridge#AmphetamineDependence
10-24	1972-1973	)	http://maven.renci.org/NeuroBridge/neurobridge#AmphetamineDependence
10-25	1974-1977	and	_
10-26	1978-1980	66	_
10-27	1981-1985	age-	_
10-28	1986-1989	and	_
10-29	1990-2004	gender-matched	_
10-30	2005-2012	healthy	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
10-31	2013-2020	control	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
10-32	2021-2022	(	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
10-33	2023-2025	HC	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
10-34	2026-2027	)	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
10-35	2028-2036	subjects	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
10-36	2037-2038	(	_
10-37	2039-2041	36	_
10-38	2042-2045	men	_
10-39	2046-2047	)	_
10-40	2048-2060	participated	_
10-41	2061-2063	in	_
10-42	2064-2067	the	_
10-43	2068-2073	study	_
10-44	2074-2075	(	_
10-45	2076-2089	Supplementary	_
10-46	2090-2095	Table	_
10-47	2096-2097	1	_
10-48	2098-2099	)	_
10-49	2100-2101	.	_

Text=CD met criteria for current cocaine dependence, as diagnosed by the Structured Clinical Interview for DSM-IV.
11-1	2102-2104	CD	_
11-2	2105-2108	met	_
11-3	2109-2117	criteria	_
11-4	2118-2121	for	_
11-5	2122-2129	current	_
11-6	2130-2137	cocaine	_
11-7	2138-2148	dependence	http://maven.renci.org/NeuroBridge/neurobridge#PolysubstanceDependence
11-8	2149-2150	,	_
11-9	2151-2153	as	_
11-10	2154-2163	diagnosed	_
11-11	2164-2166	by	_
11-12	2167-2170	the	_
11-13	2171-2181	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
11-14	2182-2190	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
11-15	2191-2200	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
11-16	2201-2204	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
11-17	2205-2211	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
11-18	2212-2213	.	_

Text=Recent cocaine use was confirmed by urine toxicology screens.
12-1	2214-2220	Recent	_
12-2	2221-2228	cocaine	_
12-3	2229-2232	use	_
12-4	2233-2236	was	_
12-5	2237-2246	confirmed	_
12-6	2247-2249	by	_
12-7	2250-2255	urine	_
12-8	2256-2266	toxicology	_
12-9	2267-2274	screens	_
12-10	2275-2276	.	_

Text=CD were drug-free while staying in an inpatient unit prior to the current fMRI study.
13-1	2277-2279	CD	_
13-2	2280-2284	were	_
13-3	2285-2294	drug-free	_
13-4	2295-2300	while	_
13-5	2301-2308	staying	_
13-6	2309-2311	in	_
13-7	2312-2314	an	_
13-8	2315-2324	inpatient	_
13-9	2325-2329	unit	_
13-10	2330-2335	prior	_
13-11	2336-2338	to	_
13-12	2339-2342	the	_
13-13	2343-2350	current	_
13-14	2351-2355	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
13-15	2356-2361	study	_
13-16	2362-2363	.	_

Text=All subjects were physically healthy with no major medical illnesses or current use of prescription medications.
14-1	2364-2367	All	_
14-2	2368-2376	subjects	_
14-3	2377-2381	were	_
14-4	2382-2392	physically	_
14-5	2393-2400	healthy	_
14-6	2401-2405	with	_
14-7	2406-2408	no	_
14-8	2409-2414	major	_
14-9	2415-2422	medical	_
14-10	2423-2432	illnesses	_
14-11	2433-2435	or	_
14-12	2436-2443	current	_
14-13	2444-2447	use	_
14-14	2448-2450	of	_
14-15	2451-2463	prescription	_
14-16	2464-2475	medications	_
14-17	2476-2477	.	_

Text=None reported having a history of head injury or neurological illness.
15-1	2478-2482	None	_
15-2	2483-2491	reported	_
15-3	2492-2498	having	_
15-4	2499-2500	a	_
15-5	2501-2508	history	_
15-6	2509-2511	of	_
15-7	2512-2516	head	_
15-8	2517-2523	injury	_
15-9	2524-2526	or	_
15-10	2527-2539	neurological	_
15-11	2540-2547	illness	_
15-12	2548-2549	.	_

Text=Other exclusion criteria included dependence on another psychoactive substance (except nicotine) and current or past history of psychotic disorders.
16-1	2550-2555	Other	_
16-2	2556-2565	exclusion	_
16-3	2566-2574	criteria	_
16-4	2575-2583	included	_
16-5	2584-2594	dependence	_
16-6	2595-2597	on	_
16-7	2598-2605	another	_
16-8	2606-2618	psychoactive	_
16-9	2619-2628	substance	_
16-10	2629-2630	(	_
16-11	2631-2637	except	_
16-12	2638-2646	nicotine	_
16-13	2647-2648	)	_
16-14	2649-2652	and	_
16-15	2653-2660	current	_
16-16	2661-2663	or	_
16-17	2664-2668	past	_
16-18	2669-2676	history	_
16-19	2677-2679	of	_
16-20	2680-2689	psychotic	_
16-21	2690-2699	disorders	_
16-22	2700-2701	.	_

Text=Individuals with current depressive or anxiety symptoms requiring treatment or currently being treated for these symptoms were excluded as well.
17-1	2702-2713	Individuals	_
17-2	2714-2718	with	_
17-3	2719-2726	current	_
17-4	2727-2737	depressive	_
17-5	2738-2740	or	_
17-6	2741-2748	anxiety	_
17-7	2749-2757	symptoms	_
17-8	2758-2767	requiring	_
17-9	2768-2777	treatment	_
17-10	2778-2780	or	_
17-11	2781-2790	currently	_
17-12	2791-2796	being	_
17-13	2797-2804	treated	_
17-14	2805-2808	for	_
17-15	2809-2814	these	_
17-16	2815-2823	symptoms	_
17-17	2824-2828	were	_
17-18	2829-2837	excluded	_
17-19	2838-2840	as	_
17-20	2841-2845	well	_
17-21	2846-2847	.	_

Text=The Human Investigation committee at Yale University School of Medicine approved all study procedures, and all subjects signed an informed consent prior to study participation.
18-1	2848-2851	The	_
18-2	2852-2857	Human	_
18-3	2858-2871	Investigation	_
18-4	2872-2881	committee	_
18-5	2882-2884	at	_
18-6	2885-2889	Yale	_
18-7	2890-2900	University	_
18-8	2901-2907	School	_
18-9	2908-2910	of	_
18-10	2911-2919	Medicine	_
18-11	2920-2928	approved	_
18-12	2929-2932	all	_
18-13	2933-2938	study	_
18-14	2939-2949	procedures	_
18-15	2950-2951	,	_
18-16	2952-2955	and	_
18-17	2956-2959	all	_
18-18	2960-2968	subjects	_
18-19	2969-2975	signed	_
18-20	2976-2978	an	_
18-21	2979-2987	informed	_
18-22	2988-2995	consent	_
18-23	2996-3001	prior	_
18-24	3002-3004	to	_
18-25	3005-3010	study	_
18-26	3011-3024	participation	_
18-27	3025-3026	.	_

Text=CD ’ s were assessed with the Beck Depression Inventory and the State-Trait Anxiety Inventory at admission.
19-1	3027-3029	CD	_
19-2	3030-3031	’	_
19-3	3032-3033	s	_
19-4	3034-3038	were	_
19-5	3039-3047	assessed	_
19-6	3048-3052	with	_
19-7	3053-3056	the	_
19-8	3057-3061	Beck	_
19-9	3062-3072	Depression	http://maven.renci.org/NeuroBridge/neurobridge#BeckDepressionInventory
19-10	3073-3082	Inventory	http://maven.renci.org/NeuroBridge/neurobridge#BeckDepressionInventory
19-11	3083-3086	and	_
19-12	3087-3090	the	_
19-13	3091-3102	State-Trait	http://maven.renci.org/NeuroBridge/neurobridge#TraitAnxietyInventory
19-14	3103-3110	Anxiety	http://maven.renci.org/NeuroBridge/neurobridge#TraitAnxietyInventory
19-15	3111-3120	Inventory	http://maven.renci.org/NeuroBridge/neurobridge#TraitAnxietyInventory
19-16	3121-3123	at	_
19-17	3124-3133	admission	_
19-18	3134-3135	.	_

Text=The mean (± SD) BDI (9.5 ± 8.1) and STAI state (33.8 ± 11.0) and trait (38.3 ± 9.8) scores were within the range reported previously for individuals with cocaine dependence.
20-1	3136-3139	The	_
20-2	3140-3144	mean	_
20-3	3145-3146	(	_
20-4	3147-3148	±	_
20-5	3149-3151	SD	_
20-6	3152-3153	)	_
20-7	3154-3157	BDI	_
20-8	3158-3159	(	_
20-9	3160-3163	9.5	_
20-10	3164-3165	±	_
20-11	3166-3169	8.1	_
20-12	3170-3171	)	_
20-13	3172-3175	and	_
20-14	3176-3180	STAI	_
20-15	3181-3186	state	_
20-16	3187-3188	(	_
20-17	3189-3193	33.8	_
20-18	3194-3195	±	_
20-19	3196-3200	11.0	_
20-20	3201-3202	)	_
20-21	3203-3206	and	_
20-22	3207-3212	trait	_
20-23	3213-3214	(	_
20-24	3215-3219	38.3	_
20-25	3220-3221	±	_
20-26	3222-3225	9.8	_
20-27	3226-3227	)	_
20-28	3228-3234	scores	_
20-29	3235-3239	were	_
20-30	3240-3246	within	_
20-31	3247-3250	the	_
20-32	3251-3256	range	_
20-33	3257-3265	reported	_
20-34	3266-3276	previously	_
20-35	3277-3280	for	_
20-36	3281-3292	individuals	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
20-37	3293-3297	with	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorderStatus
20-38	3298-3305	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
20-39	3306-3316	dependence	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
20-40	3317-3318	.	_

Text=Cocaine craving was assessed with the cocaine craving questionnaire, brief version (CCQ-Brief), for all participants every two to three days.
21-1	3319-3326	Cocaine	_
21-2	3327-3334	craving	_
21-3	3335-3338	was	_
21-4	3339-3347	assessed	_
21-5	3348-3352	with	_
21-6	3353-3356	the	_
21-7	3357-3364	cocaine	_
21-8	3365-3372	craving	_
21-9	3373-3386	questionnaire	_
21-10	3387-3388	,	_
21-11	3389-3394	brief	_
21-12	3395-3402	version	_
21-13	3403-3404	(	_
21-14	3405-3414	CCQ-Brief	_
21-15	3415-3416	)	_
21-16	3417-3418	,	_
21-17	3419-3422	for	_
21-18	3423-3426	all	_
21-19	3427-3439	participants	_
21-20	3440-3445	every	_
21-21	3446-3449	two	_
21-22	3450-3452	to	_
21-23	3453-3458	three	_
21-24	3459-3463	days	_
21-25	3464-3465	.	_

Text=The CCQ-Brief is a 10-item questionnaire, abbreviated from the CCQ-Now.
22-1	3466-3469	The	_
22-2	3470-3479	CCQ-Brief	_
22-3	3480-3482	is	_
22-4	3483-3484	a	_
22-5	3485-3492	10-item	_
22-6	3493-3506	questionnaire	_
22-7	3507-3508	,	_
22-8	3509-3520	abbreviated	_
22-9	3521-3525	from	_
22-10	3526-3529	the	_
22-11	3530-3537	CCQ-Now	_
22-12	3538-3539	.	_

Text=It is highly correlated with the CCQ-Now and other cocaine craving measures.
23-1	3540-3542	It	_
23-2	3543-3545	is	_
23-3	3546-3552	highly	_
23-4	3553-3563	correlated	_
23-5	3564-3568	with	_
23-6	3569-3572	the	_
23-7	3573-3580	CCQ-Now	_
23-8	3581-3584	and	_
23-9	3585-3590	other	_
23-10	3591-3598	cocaine	_
23-11	3599-3606	craving	_
23-12	3607-3615	measures	_
23-13	3616-3617	.	_

Text=Each item was rated on a scale from 1 to 7, with a higher total score (ranging from 10 to 70) indicating greater craving.
24-1	3618-3622	Each	_
24-2	3623-3627	item	_
24-3	3628-3631	was	_
24-4	3632-3637	rated	_
24-5	3638-3640	on	_
24-6	3641-3642	a	_
24-7	3643-3648	scale	_
24-8	3649-3653	from	_
24-9	3654-3655	1	_
24-10	3656-3658	to	_
24-11	3659-3660	7	_
24-12	3661-3662	,	_
24-13	3663-3667	with	_
24-14	3668-3669	a	_
24-15	3670-3676	higher	_
24-16	3677-3682	total	_
24-17	3683-3688	score	_
24-18	3689-3690	(	_
24-19	3691-3698	ranging	_
24-20	3699-3703	from	_
24-21	3704-3706	10	_
24-22	3707-3709	to	_
24-23	3710-3712	70	_
24-24	3713-3714	)	_
24-25	3715-3725	indicating	_
24-26	3726-3733	greater	_
24-27	3734-3741	craving	_
24-28	3742-3743	.	_

Text=CD showed a CCQ score of 23.8 ± 10.4 across all assessments.
25-1	3744-3746	CD	_
25-2	3747-3753	showed	_
25-3	3754-3755	a	_
25-4	3756-3759	CCQ	_
25-5	3760-3765	score	_
25-6	3766-3768	of	_
25-7	3769-3773	23.8	_
25-8	3774-3775	±	_
25-9	3776-3780	10.4	_
25-10	3781-3787	across	_
25-11	3788-3791	all	_
25-12	3792-3803	assessments	_
25-13	3804-3805	.	_

Text=Imaging protocol Conventional T1-weighted spin echo sagittal anatomical images were acquired for slice localization using a 3 T scanner (Siemens Trio).
26-1	3806-3813	Imaging	_
26-2	3814-3822	protocol	_
26-3	3823-3835	Conventional	_
26-4	3836-3847	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
26-5	3848-3852	spin	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
26-6	3853-3857	echo	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
26-7	3858-3866	sagittal	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
26-8	3867-3877	anatomical	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
26-9	3878-3884	images	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
26-10	3885-3889	were	_
26-11	3890-3898	acquired	_
26-12	3899-3902	for	_
26-13	3903-3908	slice	_
26-14	3909-3921	localization	_
26-15	3922-3927	using	_
26-16	3928-3929	a	_
26-17	3930-3931	3	_
26-18	3932-3933	T	_
26-19	3934-3941	scanner	_
26-20	3942-3943	(	_
26-21	3944-3951	Siemens	_
26-22	3952-3956	Trio	_
26-23	3957-3958	)	_
26-24	3959-3960	.	_

Text=Anatomical images of the functional slice locations were next obtained with spin echo imaging in the axial plane parallel to the AC–PC line with TR = 300 ms, TE = 2.5 ms, bandwidth = 300 Hz/pixel, flip angle = 60°, field of view = 220 × 220 mm, matrix = 256 × 256, 32 slices with slice thickness = 4 mm and no gap.
27-1	3961-3971	Anatomical	_
27-2	3972-3978	images	_
27-3	3979-3981	of	_
27-4	3982-3985	the	_
27-5	3986-3996	functional	_
27-6	3997-4002	slice	_
27-7	4003-4012	locations	_
27-8	4013-4017	were	_
27-9	4018-4022	next	_
27-10	4023-4031	obtained	_
27-11	4032-4036	with	_
27-12	4037-4041	spin	_
27-13	4042-4046	echo	_
27-14	4047-4054	imaging	_
27-15	4055-4057	in	_
27-16	4058-4061	the	_
27-17	4062-4067	axial	_
27-18	4068-4073	plane	_
27-19	4074-4082	parallel	_
27-20	4083-4085	to	_
27-21	4086-4089	the	_
27-22	4090-4095	AC–PC	_
27-23	4096-4100	line	_
27-24	4101-4105	with	_
27-25	4106-4108	TR	_
27-26	4109-4110	=	_
27-27	4111-4114	300	_
27-28	4115-4117	ms	_
27-29	4118-4119	,	_
27-30	4120-4122	TE	_
27-31	4123-4124	=	_
27-32	4125-4128	2.5	_
27-33	4129-4131	ms	_
27-34	4132-4133	,	_
27-35	4134-4143	bandwidth	_
27-36	4144-4145	=	_
27-37	4146-4149	300	_
27-38	4150-4158	Hz/pixel	_
27-39	4159-4160	,	_
27-40	4161-4165	flip	_
27-41	4166-4171	angle	_
27-42	4172-4173	=	_
27-43	4174-4177	60°	_
27-44	4178-4179	,	_
27-45	4180-4185	field	_
27-46	4186-4188	of	_
27-47	4189-4193	view	_
27-48	4194-4195	=	_
27-49	4196-4199	220	_
27-50	4200-4201	×	_
27-51	4202-4205	220	_
27-52	4206-4208	mm	_
27-53	4209-4210	,	_
27-54	4211-4217	matrix	_
27-55	4218-4219	=	_
27-56	4220-4223	256	_
27-57	4224-4225	×	_
27-58	4226-4229	256	_
27-59	4230-4231	,	_
27-60	4232-4234	32	_
27-61	4235-4241	slices	_
27-62	4242-4246	with	_
27-63	4247-4252	slice	_
27-64	4253-4262	thickness	_
27-65	4263-4264	=	_
27-66	4265-4266	4	_
27-67	4267-4269	mm	_
27-68	4270-4273	and	_
27-69	4274-4276	no	_
27-70	4277-4280	gap	_
27-71	4281-4282	.	_

Text=Functional, blood oxygenation level-dependent (BOLD) signals were then acquired with a single-shot gradient echo echoplanar imaging (EPI) sequence during a resting state (one scan per participant; duration: 10 minutes; eyes closed).
28-1	4283-4293	Functional	http://maven.renci.org/NeuroBridge/neurobridge#BloodOxygenLevel
28-2	4294-4295	,	http://maven.renci.org/NeuroBridge/neurobridge#BloodOxygenLevel
28-3	4296-4301	blood	http://maven.renci.org/NeuroBridge/neurobridge#BloodOxygenLevel
28-4	4302-4313	oxygenation	http://maven.renci.org/NeuroBridge/neurobridge#BloodOxygenLevel
28-5	4314-4329	level-dependent	http://maven.renci.org/NeuroBridge/neurobridge#BloodOxygenLevel
28-6	4330-4331	(	http://maven.renci.org/NeuroBridge/neurobridge#BloodOxygenLevel
28-7	4332-4336	BOLD	http://maven.renci.org/NeuroBridge/neurobridge#BloodOxygenLevel
28-8	4337-4338	)	http://maven.renci.org/NeuroBridge/neurobridge#BloodOxygenLevel
28-9	4339-4346	signals	http://maven.renci.org/NeuroBridge/neurobridge#BloodOxygenLevel
28-10	4347-4351	were	_
28-11	4352-4356	then	_
28-12	4357-4365	acquired	_
28-13	4366-4370	with	_
28-14	4371-4372	a	_
28-15	4373-4384	single-shot	_
28-16	4385-4393	gradient	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
28-17	4394-4398	echo	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
28-18	4399-4409	echoplanar	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
28-19	4410-4417	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
28-20	4418-4419	(	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
28-21	4420-4423	EPI	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
28-22	4424-4425	)	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
28-23	4426-4434	sequence	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
28-24	4435-4441	during	_
28-25	4442-4443	a	_
28-26	4444-4451	resting	_
28-27	4452-4457	state	_
28-28	4458-4459	(	_
28-29	4460-4463	one	_
28-30	4464-4468	scan	_
28-31	4469-4472	per	_
28-32	4473-4484	participant	_
28-33	4485-4486	;	_
28-34	4487-4495	duration	_
28-35	4496-4497	:	_
28-36	4498-4500	10	_
28-37	4501-4508	minutes	_
28-38	4509-4510	;	_
28-39	4511-4515	eyes	_
28-40	4516-4522	closed	_
28-41	4523-4524	)	_
28-42	4525-4526	.	_

Text=Thirty-two axial slices parallel to the AC–PC line covering the whole brain were acquired with TR = 2000 ms, TE = 25 ms, bandwidth = 2004 Hz/pixel, flip angle = 85°, field of view = 220 × 220 mm, matrix = 64 × 64, 32 slices with slice thickness = 4 mm and no gap.
29-1	4527-4537	Thirty-two	_
29-2	4538-4543	axial	_
29-3	4544-4550	slices	_
29-4	4551-4559	parallel	_
29-5	4560-4562	to	_
29-6	4563-4566	the	_
29-7	4567-4572	AC–PC	_
29-8	4573-4577	line	_
29-9	4578-4586	covering	_
29-10	4587-4590	the	_
29-11	4591-4596	whole	_
29-12	4597-4602	brain	_
29-13	4603-4607	were	_
29-14	4608-4616	acquired	_
29-15	4617-4621	with	_
29-16	4622-4624	TR	_
29-17	4625-4626	=	_
29-18	4627-4631	2000	_
29-19	4632-4634	ms	_
29-20	4635-4636	,	_
29-21	4637-4639	TE	_
29-22	4640-4641	=	_
29-23	4642-4644	25	_
29-24	4645-4647	ms	_
29-25	4648-4649	,	_
29-26	4650-4659	bandwidth	_
29-27	4660-4661	=	_
29-28	4662-4666	2004	_
29-29	4667-4675	Hz/pixel	_
29-30	4676-4677	,	_
29-31	4678-4682	flip	_
29-32	4683-4688	angle	_
29-33	4689-4690	=	_
29-34	4691-4694	85°	_
29-35	4695-4696	,	_
29-36	4697-4702	field	_
29-37	4703-4705	of	_
29-38	4706-4710	view	_
29-39	4711-4712	=	_
29-40	4713-4716	220	_
29-41	4717-4718	×	_
29-42	4719-4722	220	_
29-43	4723-4725	mm	_
29-44	4726-4727	,	_
29-45	4728-4734	matrix	_
29-46	4735-4736	=	_
29-47	4737-4739	64	_
29-48	4740-4741	×	_
29-49	4742-4744	64	_
29-50	4745-4746	,	_
29-51	4747-4749	32	_
29-52	4750-4756	slices	_
29-53	4757-4761	with	_
29-54	4762-4767	slice	_
29-55	4768-4777	thickness	_
29-56	4778-4779	=	_
29-57	4780-4781	4	_
29-58	4782-4784	mm	_
29-59	4785-4788	and	_
29-60	4789-4791	no	_
29-61	4792-4795	gap	_
29-62	4796-4797	.	_

Text=Imaging data preprocessing Figure 1a illustrates the step by step procedures in data analysis.
30-1	4798-4805	Imaging	_
30-2	4806-4810	data	_
30-3	4811-4824	preprocessing	_
30-4	4825-4831	Figure	_
30-5	4832-4834	1a	_
30-6	4835-4846	illustrates	_
30-7	4847-4850	the	_
30-8	4851-4855	step	_
30-9	4856-4858	by	_
30-10	4859-4863	step	_
30-11	4864-4874	procedures	_
30-12	4875-4877	in	_
30-13	4878-4882	data	_
30-14	4883-4891	analysis	_
30-15	4892-4893	.	_

Text=The data were processed with Statistical Parametric Mapping (SPM8, Wellcome Department of Imaging Neuroscience, University College London, U.K.).
31-1	4894-4897	The	_
31-2	4898-4902	data	_
31-3	4903-4907	were	_
31-4	4908-4917	processed	_
31-5	4918-4922	with	_
31-6	4923-4934	Statistical	_
31-7	4935-4945	Parametric	_
31-8	4946-4953	Mapping	_
31-9	4954-4955	(	_
31-10	4956-4960	SPM8	_
31-11	4961-4962	,	_
31-12	4963-4971	Wellcome	_
31-13	4972-4982	Department	_
31-14	4983-4985	of	_
31-15	4986-4993	Imaging	_
31-16	4994-5006	Neuroscience	_
31-17	5007-5008	,	_
31-18	5009-5019	University	_
31-19	5020-5027	College	_
31-20	5028-5034	London	_
31-21	5035-5036	,	_
31-22	5037-5041	U.K.	_
31-23	5042-5043	)	_
31-24	5044-5045	.	_

Text=Images from the first five TRs at the beginning of each session were discarded.
32-1	5046-5052	Images	_
32-2	5053-5057	from	_
32-3	5058-5061	the	_
32-4	5062-5067	first	_
32-5	5068-5072	five	_
32-6	5073-5076	TRs	_
32-7	5077-5079	at	_
32-8	5080-5083	the	_
32-9	5084-5093	beginning	_
32-10	5094-5096	of	_
32-11	5097-5101	each	_
32-12	5102-5109	session	_
32-13	5110-5114	were	_
32-14	5115-5124	discarded	_
32-15	5125-5126	.	_

Text=Images of each individual subject were first realigned (motion corrected) and corrected for slice timing.
33-1	5127-5133	Images	_
33-2	5134-5136	of	_
33-3	5137-5141	each	_
33-4	5142-5152	individual	_
33-5	5153-5160	subject	_
33-6	5161-5165	were	_
33-7	5166-5171	first	_
33-8	5172-5181	realigned	_
33-9	5182-5183	(	_
33-10	5184-5190	motion	_
33-11	5191-5200	corrected	_
33-12	5201-5202	)	_
33-13	5203-5206	and	_
33-14	5207-5216	corrected	_
33-15	5217-5220	for	_
33-16	5221-5226	slice	_
33-17	5227-5233	timing	_
33-18	5234-5235	.	_

Text=A mean functional image volume was constructed from the realigned image volumes.
34-1	5236-5237	A	_
34-2	5238-5242	mean	_
34-3	5243-5253	functional	_
34-4	5254-5259	image	_
34-5	5260-5266	volume	_
34-6	5267-5270	was	_
34-7	5271-5282	constructed	_
34-8	5283-5287	from	_
34-9	5288-5291	the	_
34-10	5292-5301	realigned	_
34-11	5302-5307	image	_
34-12	5308-5315	volumes	_
34-13	5316-5317	.	_

Text=These mean images were co-registered with the high-resolution structural image and segmented for normalization with affine registration followed by nonlinear transformation.
35-1	5318-5323	These	_
35-2	5324-5328	mean	_
35-3	5329-5335	images	_
35-4	5336-5340	were	_
35-5	5341-5354	co-registered	_
35-6	5355-5359	with	_
35-7	5360-5363	the	_
35-8	5364-5379	high-resolution	_
35-9	5380-5390	structural	_
35-10	5391-5396	image	_
35-11	5397-5400	and	_
35-12	5401-5410	segmented	_
35-13	5411-5414	for	_
35-14	5415-5428	normalization	_
35-15	5429-5433	with	_
35-16	5434-5440	affine	_
35-17	5441-5453	registration	_
35-18	5454-5462	followed	_
35-19	5463-5465	by	_
35-20	5466-5475	nonlinear	_
35-21	5476-5490	transformation	_
35-22	5491-5492	.	_

Text=The normalization parameters determined for the structure volume were then applied to the corresponding functional image volumes for each subject.
36-1	5493-5496	The	_
36-2	5497-5510	normalization	_
36-3	5511-5521	parameters	_
36-4	5522-5532	determined	_
36-5	5533-5536	for	_
36-6	5537-5540	the	_
36-7	5541-5550	structure	_
36-8	5551-5557	volume	_
36-9	5558-5562	were	_
36-10	5563-5567	then	_
36-11	5568-5575	applied	_
36-12	5576-5578	to	_
36-13	5579-5582	the	_
36-14	5583-5596	corresponding	_
36-15	5597-5607	functional	_
36-16	5608-5613	image	_
36-17	5614-5621	volumes	_
36-18	5622-5625	for	_
36-19	5626-5630	each	_
36-20	5631-5638	subject	_
36-21	5639-5640	.	_

Text=Finally, the images were smoothed with a Gaussian kernel of 4 mm at Full Width at Half Maximum.
37-1	5641-5648	Finally	_
37-2	5649-5650	,	_
37-3	5651-5654	the	_
37-4	5655-5661	images	_
37-5	5662-5666	were	_
37-6	5667-5675	smoothed	_
37-7	5676-5680	with	_
37-8	5681-5682	a	_
37-9	5683-5691	Gaussian	_
37-10	5692-5698	kernel	_
37-11	5699-5701	of	_
37-12	5702-5703	4	_
37-13	5704-5706	mm	_
37-14	5707-5709	at	_
37-15	5710-5714	Full	_
37-16	5715-5720	Width	_
37-17	5721-5723	at	_
37-18	5724-5728	Half	_
37-19	5729-5736	Maximum	_
37-20	5737-5738	.	_

Text=Additional preprocessing was applied to reduce spurious BOLD variances that were unlikely to reflect neuronal activity.
38-1	5739-5749	Additional	_
38-2	5750-5763	preprocessing	_
38-3	5764-5767	was	_
38-4	5768-5775	applied	_
38-5	5776-5778	to	_
38-6	5779-5785	reduce	_
38-7	5786-5794	spurious	_
38-8	5795-5799	BOLD	_
38-9	5800-5809	variances	_
38-10	5810-5814	that	_
38-11	5815-5819	were	_
38-12	5820-5828	unlikely	_
38-13	5829-5831	to	_
38-14	5832-5839	reflect	_
38-15	5840-5848	neuronal	_
38-16	5849-5857	activity	_
38-17	5858-5859	.	_

Text=The sources of spurious variance were removed through linear regression by including the signal from the ventricular system, white matter, and whole brain, in addition to the six parameters obtained by rigid body head motion correction.
39-1	5860-5863	The	_
39-2	5864-5871	sources	_
39-3	5872-5874	of	_
39-4	5875-5883	spurious	_
39-5	5884-5892	variance	_
39-6	5893-5897	were	_
39-7	5898-5905	removed	_
39-8	5906-5913	through	_
39-9	5914-5920	linear	_
39-10	5921-5931	regression	_
39-11	5932-5934	by	_
39-12	5935-5944	including	_
39-13	5945-5948	the	_
39-14	5949-5955	signal	_
39-15	5956-5960	from	_
39-16	5961-5964	the	_
39-17	5965-5976	ventricular	_
39-18	5977-5983	system	_
39-19	5984-5985	,	_
39-20	5986-5991	white	_
39-21	5992-5998	matter	_
39-22	5999-6000	,	_
39-23	6001-6004	and	_
39-24	6005-6010	whole	_
39-25	6011-6016	brain	_
39-26	6017-6018	,	_
39-27	6019-6021	in	_
39-28	6022-6030	addition	_
39-29	6031-6033	to	_
39-30	6034-6037	the	_
39-31	6038-6041	six	_
39-32	6042-6052	parameters	_
39-33	6053-6061	obtained	_
39-34	6062-6064	by	_
39-35	6065-6070	rigid	_
39-36	6071-6075	body	_
39-37	6076-6080	head	_
39-38	6081-6087	motion	_
39-39	6088-6098	correction	_
39-40	6099-6100	.	_

Text=First-order derivatives of the whole brain, ventricular and white matter signals were also included in the regression.
40-1	6101-6112	First-order	_
40-2	6113-6124	derivatives	_
40-3	6125-6127	of	_
40-4	6128-6131	the	_
40-5	6132-6137	whole	_
40-6	6138-6143	brain	_
40-7	6144-6145	,	_
40-8	6146-6157	ventricular	_
40-9	6158-6161	and	_
40-10	6162-6167	white	_
40-11	6168-6174	matter	_
40-12	6175-6182	signals	_
40-13	6183-6187	were	_
40-14	6188-6192	also	_
40-15	6193-6201	included	_
40-16	6202-6204	in	_
40-17	6205-6208	the	_
40-18	6209-6219	regression	_
40-19	6220-6221	.	_

Text=Cordes and colleagues suggested that BOLD fluctuations below a frequency of 0.1 Hz contribute to regionally specific BOLD correlations.
41-1	6222-6228	Cordes	_
41-2	6229-6232	and	_
41-3	6233-6243	colleagues	_
41-4	6244-6253	suggested	_
41-5	6254-6258	that	_
41-6	6259-6263	BOLD	_
41-7	6264-6276	fluctuations	_
41-8	6277-6282	below	_
41-9	6283-6284	a	_
41-10	6285-6294	frequency	_
41-11	6295-6297	of	_
41-12	6298-6301	0.1	_
41-13	6302-6304	Hz	_
41-14	6305-6315	contribute	_
41-15	6316-6318	to	_
41-16	6319-6329	regionally	_
41-17	6330-6338	specific	_
41-18	6339-6343	BOLD	_
41-19	6344-6356	correlations	_
41-20	6357-6358	.	_

Text=Thus, we applied a temporal band-pass filter (0.009 Hz <f <0.08 Hz) to the time course in order to obtain low-frequency fluctuations, as in previous studies.
42-1	6359-6363	Thus	_
42-2	6364-6365	,	_
42-3	6366-6368	we	_
42-4	6369-6376	applied	_
42-5	6377-6378	a	_
42-6	6379-6387	temporal	_
42-7	6388-6397	band-pass	_
42-8	6398-6404	filter	_
42-9	6405-6406	(	_
42-10	6407-6412	0.009	_
42-11	6413-6415	Hz	_
42-12	6416-6417	<	_
42-13	6418-6419	f	_
42-14	6420-6421	<	_
42-15	6422-6426	0.08	_
42-16	6427-6429	Hz	_
42-17	6430-6431	)	_
42-18	6432-6434	to	_
42-19	6435-6438	the	_
42-20	6439-6443	time	_
42-21	6444-6450	course	_
42-22	6451-6453	in	_
42-23	6454-6459	order	_
42-24	6460-6462	to	_
42-25	6463-6469	obtain	_
42-26	6470-6483	low-frequency	_
42-27	6484-6496	fluctuations	_
42-28	6497-6498	,	_
42-29	6499-6501	as	_
42-30	6502-6504	in	_
42-31	6505-6513	previous	_
42-32	6514-6521	studies	_
42-33	6522-6523	.	_

Text=Head motion As extensively investigated in previous study, micro head motion (> 0.1 mm) is an important source of spurious correlations in resting state functional connectivity analysis.
43-1	6524-6528	Head	_
43-2	6529-6535	motion	_
43-3	6536-6538	As	_
43-4	6539-6550	extensively	_
43-5	6551-6563	investigated	_
43-6	6564-6566	in	_
43-7	6567-6575	previous	_
43-8	6576-6581	study	_
43-9	6582-6583	,	_
43-10	6584-6589	micro	_
43-11	6590-6594	head	_
43-12	6595-6601	motion	_
43-13	6602-6603	(	_
43-14	6604-6605	>	_
43-15	6606-6609	0.1	_
43-16	6610-6612	mm	_
43-17	6613-6614	)	_
43-18	6615-6617	is	_
43-19	6618-6620	an	_
43-20	6621-6630	important	_
43-21	6631-6637	source	_
43-22	6638-6640	of	_
43-23	6641-6649	spurious	_
43-24	6650-6662	correlations	_
43-25	6663-6665	in	_
43-26	6666-6673	resting	_
43-27	6674-6679	state	_
43-28	6680-6690	functional	_
43-29	6691-6703	connectivity	_
43-30	6704-6712	analysis	_
43-31	6713-6714	.	_

Text=Therefore, we applied a “ scrubbing ” method proposed by Power and colleagues and successfully applied in previous studies to remove time points affected by head motions, prior to temporal band-pass filtering.
44-1	6715-6724	Therefore	_
44-2	6725-6726	,	_
44-3	6727-6729	we	_
44-4	6730-6737	applied	_
44-5	6738-6739	a	_
44-6	6740-6741	“	_
44-7	6742-6751	scrubbing	_
44-8	6752-6753	”	_
44-9	6754-6760	method	_
44-10	6761-6769	proposed	_
44-11	6770-6772	by	_
44-12	6773-6778	Power	_
44-13	6779-6782	and	_
44-14	6783-6793	colleagues	_
44-15	6794-6797	and	_
44-16	6798-6810	successfully	_
44-17	6811-6818	applied	_
44-18	6819-6821	in	_
44-19	6822-6830	previous	_
44-20	6831-6838	studies	_
44-21	6839-6841	to	_
44-22	6842-6848	remove	_
44-23	6849-6853	time	_
44-24	6854-6860	points	_
44-25	6861-6869	affected	_
44-26	6870-6872	by	_
44-27	6873-6877	head	_
44-28	6878-6885	motions	_
44-29	6886-6887	,	_
44-30	6888-6893	prior	_
44-31	6894-6896	to	_
44-32	6897-6905	temporal	_
44-33	6906-6915	band-pass	_
44-34	6916-6925	filtering	_
44-35	6926-6927	.	_

Text=Briefly, for every time point t, we computed the framewise displacement given by, where (dx, dy, dz) and (α, β, γ) are the translational and rotational movements, respectively.
45-1	6928-6935	Briefly	_
45-2	6936-6937	,	_
45-3	6938-6941	for	_
45-4	6942-6947	every	_
45-5	6948-6952	time	_
45-6	6953-6958	point	_
45-7	6959-6960	t	_
45-8	6961-6962	,	_
45-9	6963-6965	we	_
45-10	6966-6974	computed	_
45-11	6975-6978	the	_
45-12	6979-6988	framewise	_
45-13	6989-7001	displacement	_
45-14	7002-7007	given	_
45-15	7008-7010	by	_
45-16	7011-7012	,	_
45-17	7013-7018	where	_
45-18	7019-7020	(	_
45-19	7021-7023	dx	_
45-20	7024-7025	,	_
45-21	7026-7028	dy	_
45-22	7029-7030	,	_
45-23	7031-7033	dz	_
45-24	7034-7035	)	_
45-25	7036-7039	and	_
45-26	7040-7041	(	_
45-27	7042-7043	α	_
45-28	7044-7045	,	_
45-29	7046-7047	β	_
45-30	7048-7049	,	_
45-31	7050-7051	γ	_
45-32	7052-7053	)	_
45-33	7054-7057	are	_
45-34	7058-7061	the	_
45-35	7062-7075	translational	_
45-36	7076-7079	and	_
45-37	7080-7090	rotational	_
45-38	7091-7100	movements	_
45-39	7101-7102	,	_
45-40	7103-7115	respectively	_
45-41	7116-7117	.	_

Text=The second head movement metric was the root mean square variance (DVARS) of the differences in% BOLD intensity I (t) between consecutive time points across brain voxels, computed as:, where the brackets indicate the mean across brain voxels.
46-1	7118-7121	The	_
46-2	7122-7128	second	_
46-3	7129-7133	head	_
46-4	7134-7142	movement	_
46-5	7143-7149	metric	_
46-6	7150-7153	was	_
46-7	7154-7157	the	_
46-8	7158-7162	root	_
46-9	7163-7167	mean	_
46-10	7168-7174	square	_
46-11	7175-7183	variance	_
46-12	7184-7185	(	_
46-13	7186-7191	DVARS	_
46-14	7192-7193	)	_
46-15	7194-7196	of	_
46-16	7197-7200	the	_
46-17	7201-7212	differences	_
46-18	7213-7215	in	_
46-19	7216-7217	%	_
46-20	7218-7222	BOLD	_
46-21	7223-7232	intensity	_
46-22	7233-7234	I	_
46-23	7235-7236	(	_
46-24	7237-7238	t	_
46-25	7239-7240	)	_
46-26	7241-7248	between	_
46-27	7249-7260	consecutive	_
46-28	7261-7265	time	_
46-29	7266-7272	points	_
46-30	7273-7279	across	_
46-31	7280-7285	brain	_
46-32	7286-7292	voxels	_
46-33	7293-7294	,	_
46-34	7295-7303	computed	_
46-35	7304-7306	as	_
46-36	7307-7308	:	_
46-37	7309-7310	,	_
46-38	7311-7316	where	_
46-39	7317-7320	the	_
46-40	7321-7329	brackets	_
46-41	7330-7338	indicate	_
46-42	7339-7342	the	_
46-43	7343-7347	mean	_
46-44	7348-7354	across	_
46-45	7355-7360	brain	_
46-46	7361-7367	voxels	_
46-47	7368-7369	.	_

Text=Finally, to compute each subject ’ s correlation map, we removed every time point with FD (t)> 0.5 mm or DVARS (t)> 0.5%.
47-1	7370-7377	Finally	_
47-2	7378-7379	,	_
47-3	7380-7382	to	_
47-4	7383-7390	compute	_
47-5	7391-7395	each	_
47-6	7396-7403	subject	_
47-7	7404-7405	’	_
47-8	7406-7407	s	_
47-9	7408-7419	correlation	_
47-10	7420-7423	map	_
47-11	7424-7425	,	_
47-12	7426-7428	we	_
47-13	7429-7436	removed	_
47-14	7437-7442	every	_
47-15	7443-7447	time	_
47-16	7448-7453	point	_
47-17	7454-7458	with	_
47-18	7459-7461	FD	_
47-19	7462-7463	(	_
47-20	7464-7465	t	_
47-21	7466-7467	)	_
47-22	7468-7469	>	_
47-23	7470-7473	0.5	_
47-24	7474-7476	mm	_
47-25	7477-7479	or	_
47-26	7480-7485	DVARS	_
47-27	7486-7487	(	_
47-28	7488-7489	t	_
47-29	7490-7491	)	_
47-30	7492-7493	>	_
47-31	7494-7497	0.5	_
47-32	7498-7499	%	_
47-33	7500-7501	.	_

Text=On average, 1% of the time points were removed across subjects.
48-1	7502-7504	On	_
48-2	7505-7512	average	_
48-3	7513-7514	,	_
48-4	7515-7516	1	_
48-5	7517-7518	%	_
48-6	7519-7521	of	_
48-7	7522-7525	the	_
48-8	7526-7530	time	_
48-9	7531-7537	points	_
48-10	7538-7542	were	_
48-11	7543-7550	removed	_
48-12	7551-7557	across	_
48-13	7558-7566	subjects	_
48-14	7567-7568	.	_

Text=CD and HC did not differ in either the mean FD (p = 0.76) or DVARS (p = 0.57).
49-1	7569-7571	CD	_
49-2	7572-7575	and	_
49-3	7576-7578	HC	_
49-4	7579-7582	did	_
49-5	7583-7586	not	_
49-6	7587-7593	differ	_
49-7	7594-7596	in	_
49-8	7597-7603	either	_
49-9	7604-7607	the	_
49-10	7608-7612	mean	_
49-11	7613-7615	FD	_
49-12	7616-7617	(	_
49-13	7618-7619	p	_
49-14	7620-7621	=	_
49-15	7622-7626	0.76	_
49-16	7627-7628	)	_
49-17	7629-7631	or	_
49-18	7632-7637	DVARS	_
49-19	7638-7639	(	_
49-20	7640-7641	p	_
49-21	7642-7643	=	_
49-22	7644-7648	0.57	_
49-23	7649-7650	)	_
49-24	7651-7652	.	_

Text=Parcelation of the VS based on functional connectivity differences between CD and HC As with our previous studies, we used a ventral striatum (VS) mask (Fig.
50-1	7653-7664	Parcelation	_
50-2	7665-7667	of	_
50-3	7668-7671	the	_
50-4	7672-7674	VS	_
50-5	7675-7680	based	_
50-6	7681-7683	on	_
50-7	7684-7694	functional	_
50-8	7695-7707	connectivity	_
50-9	7708-7719	differences	_
50-10	7720-7727	between	_
50-11	7728-7730	CD	_
50-12	7731-7734	and	_
50-13	7735-7737	HC	_
50-14	7738-7740	As	_
50-15	7741-7745	with	_
50-16	7746-7749	our	_
50-17	7750-7758	previous	_
50-18	7759-7766	studies	_
50-19	7767-7768	,	_
50-20	7769-7771	we	_
50-21	7772-7776	used	_
50-22	7777-7778	a	_
50-23	7779-7786	ventral	_
50-24	7787-7795	striatum	_
50-25	7796-7797	(	_
50-26	7798-7800	VS	_
50-27	7801-7802	)	_
50-28	7803-7807	mask	_
50-29	7808-7809	(	_
50-30	7810-7813	Fig	_
50-31	7814-7815	.	_

Text=1b) generated by cytoarchitectonic and topographical criteria.
51-1	7816-7818	1b	_
51-2	7819-7820	)	_
51-3	7821-7830	generated	_
51-4	7831-7833	by	_
51-5	7834-7851	cytoarchitectonic	_
51-6	7852-7855	and	_
51-7	7856-7869	topographical	_
51-8	7870-7878	criteria	_
51-9	7879-7880	.	_

Text=We employed 116 anatomical masks from the Automated Anatomical Labeling or AAL Atlas based on a Montreal Neurological Institute (MNI) template.
52-1	7881-7883	We	_
52-2	7884-7892	employed	_
52-3	7893-7896	116	_
52-4	7897-7907	anatomical	_
52-5	7908-7913	masks	_
52-6	7914-7918	from	_
52-7	7919-7922	the	_
52-8	7923-7932	Automated	_
52-9	7933-7943	Anatomical	_
52-10	7944-7952	Labeling	_
52-11	7953-7955	or	_
52-12	7956-7959	AAL	_
52-13	7960-7965	Atlas	_
52-14	7966-7971	based	_
52-15	7972-7974	on	_
52-16	7975-7976	a	_
52-17	7977-7985	Montreal	_
52-18	7986-7998	Neurological	_
52-19	7999-8008	Institute	_
52-20	8009-8010	(	_
52-21	8011-8014	MNI	_
52-22	8015-8016	)	_
52-23	8017-8025	template	_
52-24	8026-8027	.	_

Text=We averaged the BOLD time courses of voxels within each of the 116 regions and computed the correlation coefficient between the averaged time course of each AAL region and the time courses of each individual voxel of the VS for individual subjects.
53-1	8028-8030	We	_
53-2	8031-8039	averaged	_
53-3	8040-8043	the	_
53-4	8044-8048	BOLD	_
53-5	8049-8053	time	_
53-6	8054-8061	courses	_
53-7	8062-8064	of	_
53-8	8065-8071	voxels	_
53-9	8072-8078	within	_
53-10	8079-8083	each	_
53-11	8084-8086	of	_
53-12	8087-8090	the	_
53-13	8091-8094	116	_
53-14	8095-8102	regions	_
53-15	8103-8106	and	_
53-16	8107-8115	computed	_
53-17	8116-8119	the	_
53-18	8120-8131	correlation	_
53-19	8132-8143	coefficient	_
53-20	8144-8151	between	_
53-21	8152-8155	the	_
53-22	8156-8164	averaged	_
53-23	8165-8169	time	_
53-24	8170-8176	course	_
53-25	8177-8179	of	_
53-26	8180-8184	each	_
53-27	8185-8188	AAL	_
53-28	8189-8195	region	_
53-29	8196-8199	and	_
53-30	8200-8203	the	_
53-31	8204-8208	time	_
53-32	8209-8216	courses	_
53-33	8217-8219	of	_
53-34	8220-8224	each	_
53-35	8225-8235	individual	_
53-36	8236-8241	voxel	_
53-37	8242-8244	of	_
53-38	8245-8248	the	_
53-39	8249-8251	VS	_
53-40	8252-8255	for	_
53-41	8256-8266	individual	_
53-42	8267-8275	subjects	_
53-43	8276-8277	.	_

Text=To assess and compare the resting state “ correlograms (correlation matrices), ” we converted these correlation matrices, which were not normally distributed, to z score maps by Fisher ’ s z transform:.
54-1	8278-8280	To	_
54-2	8281-8287	assess	_
54-3	8288-8291	and	_
54-4	8292-8299	compare	_
54-5	8300-8303	the	_
54-6	8304-8311	resting	_
54-7	8312-8317	state	_
54-8	8318-8319	“	_
54-9	8320-8332	correlograms	_
54-10	8333-8334	(	_
54-11	8335-8346	correlation	_
54-12	8347-8355	matrices	_
54-13	8356-8357	)	_
54-14	8358-8359	,	_
54-15	8360-8361	”	_
54-16	8362-8364	we	_
54-17	8365-8374	converted	_
54-18	8375-8380	these	_
54-19	8381-8392	correlation	_
54-20	8393-8401	matrices	_
54-21	8402-8403	,	_
54-22	8404-8409	which	_
54-23	8410-8414	were	_
54-24	8415-8418	not	_
54-25	8419-8427	normally	_
54-26	8428-8439	distributed	_
54-27	8440-8441	,	_
54-28	8442-8444	to	_
54-29	8445-8446	z	_
54-30	8447-8452	score	_
54-31	8453-8457	maps	_
54-32	8458-8460	by	_
54-33	8461-8467	Fisher	_
54-34	8468-8469	’	_
54-35	8470-8471	s	_
54-36	8472-8473	z	_
54-37	8474-8483	transform	_
54-38	8484-8485	:	_
54-39	8486-8487	.	_

Text=The z maps were used in group, random effect analyses.
55-1	8488-8491	The	_
55-2	8492-8493	z	_
55-3	8494-8498	maps	_
55-4	8499-8503	were	_
55-5	8504-8508	used	_
55-6	8509-8511	in	_
55-7	8512-8517	group	_
55-8	8518-8519	,	_
55-9	8520-8526	random	_
55-10	8527-8533	effect	_
55-11	8534-8542	analyses	_
55-12	8543-8544	.	_

Text=A two-sample t test was first applied to the “ z maps ” to compare 66 CD with 66 HC for each of the 116 correlograms.
56-1	8545-8546	A	_
56-2	8547-8557	two-sample	_
56-3	8558-8559	t	_
56-4	8560-8564	test	_
56-5	8565-8568	was	_
56-6	8569-8574	first	_
56-7	8575-8582	applied	_
56-8	8583-8585	to	_
56-9	8586-8589	the	_
56-10	8590-8591	“	_
56-11	8592-8593	z	_
56-12	8594-8598	maps	_
56-13	8599-8600	”	_
56-14	8601-8603	to	_
56-15	8604-8611	compare	_
56-16	8612-8614	66	_
56-17	8615-8617	CD	_
56-18	8618-8622	with	_
56-19	8623-8625	66	_
56-20	8626-8628	HC	_
56-21	8629-8632	for	_
56-22	8633-8637	each	_
56-23	8638-8640	of	_
56-24	8641-8644	the	_
56-25	8645-8648	116	_
56-26	8649-8661	correlograms	_
56-27	8662-8663	.	_

Text=Voxels within the VS mask were subject to rsFC based segmentation, with each voxel represented by 116 t values of the two-sample t test.
57-1	8664-8670	Voxels	_
57-2	8671-8677	within	_
57-3	8678-8681	the	_
57-4	8682-8684	VS	_
57-5	8685-8689	mask	_
57-6	8690-8694	were	_
57-7	8695-8702	subject	_
57-8	8703-8705	to	_
57-9	8706-8710	rsFC	_
57-10	8711-8716	based	_
57-11	8717-8729	segmentation	_
57-12	8730-8731	,	_
57-13	8732-8736	with	_
57-14	8737-8741	each	_
57-15	8742-8747	voxel	_
57-16	8748-8759	represented	_
57-17	8760-8762	by	_
57-18	8763-8766	116	_
57-19	8767-8768	t	_
57-20	8769-8775	values	_
57-21	8776-8778	of	_
57-22	8779-8782	the	_
57-23	8783-8793	two-sample	_
57-24	8794-8795	t	_
57-25	8796-8800	test	_
57-26	8801-8802	.	_

Text=A K-means algorithm was applied to cluster the voxels within the VS on the bases of the 116 t values.
58-1	8803-8804	A	_
58-2	8805-8812	K-means	_
58-3	8813-8822	algorithm	_
58-4	8823-8826	was	_
58-5	8827-8834	applied	_
58-6	8835-8837	to	_
58-7	8838-8845	cluster	_
58-8	8846-8849	the	_
58-9	8850-8856	voxels	_
58-10	8857-8863	within	_
58-11	8864-8867	the	_
58-12	8868-8870	VS	_
58-13	8871-8873	on	_
58-14	8874-8877	the	_
58-15	8878-8883	bases	_
58-16	8884-8886	of	_
58-17	8887-8890	the	_
58-18	8891-8894	116	_
58-19	8895-8896	t	_
58-20	8897-8903	values	_
58-21	8904-8905	.	_

Text=Placing K points into the space represented by the objects that are being clustered.
59-1	8906-8913	Placing	_
59-2	8914-8915	K	_
59-3	8916-8922	points	_
59-4	8923-8927	into	_
59-5	8928-8931	the	_
59-6	8932-8937	space	_
59-7	8938-8949	represented	_
59-8	8950-8952	by	_
59-9	8953-8956	the	_
59-10	8957-8964	objects	_
59-11	8965-8969	that	_
59-12	8970-8973	are	_
59-13	8974-8979	being	_
59-14	8980-8989	clustered	_
59-15	8990-8991	.	_

Text=These points represent initial group centroids.
60-1	8992-8997	These	_
60-2	8998-9004	points	_
60-3	9005-9014	represent	_
60-4	9015-9022	initial	_
60-5	9023-9028	group	_
60-6	9029-9038	centroids	_
60-7	9039-9040	.	_

Text=Assigning each object to the group that has the closest centroid.
61-1	9041-9050	Assigning	_
61-2	9051-9055	each	_
61-3	9056-9062	object	_
61-4	9063-9065	to	_
61-5	9066-9069	the	_
61-6	9070-9075	group	_
61-7	9076-9080	that	_
61-8	9081-9084	has	_
61-9	9085-9088	the	_
61-10	9089-9096	closest	_
61-11	9097-9105	centroid	_
61-12	9106-9107	.	_

Text=Recalculating the positions of the K centroids, when all objects have been assigned.
62-1	9108-9121	Recalculating	_
62-2	9122-9125	the	_
62-3	9126-9135	positions	_
62-4	9136-9138	of	_
62-5	9139-9142	the	_
62-6	9143-9144	K	_
62-7	9145-9154	centroids	_
62-8	9155-9156	,	_
62-9	9157-9161	when	_
62-10	9162-9165	all	_
62-11	9166-9173	objects	_
62-12	9174-9178	have	_
62-13	9179-9183	been	_
62-14	9184-9192	assigned	_
62-15	9193-9194	.	_

Text=Repeating Steps 2 and 3 until the centroids no longer move.
63-1	9195-9204	Repeating	_
63-2	9205-9210	Steps	_
63-3	9211-9212	2	_
63-4	9213-9216	and	_
63-5	9217-9218	3	_
63-6	9219-9224	until	_
63-7	9225-9228	the	_
63-8	9229-9238	centroids	_
63-9	9239-9241	no	_
63-10	9242-9248	longer	_
63-11	9249-9253	move	_
63-12	9254-9255	.	_

Text=This produces a separation of the objects into groups from which the metric to be minimized can be calculated.
64-1	9256-9260	This	_
64-2	9261-9269	produces	_
64-3	9270-9271	a	_
64-4	9272-9282	separation	_
64-5	9283-9285	of	_
64-6	9286-9289	the	_
64-7	9290-9297	objects	_
64-8	9298-9302	into	_
64-9	9303-9309	groups	_
64-10	9310-9314	from	_
64-11	9315-9320	which	_
64-12	9321-9324	the	_
64-13	9325-9331	metric	_
64-14	9332-9334	to	_
64-15	9335-9337	be	_
64-16	9338-9347	minimized	_
64-17	9348-9351	can	_
64-18	9352-9354	be	_
64-19	9355-9365	calculated	_
64-20	9366-9367	.	_

Text=As an unsupervised learning algorithm, K-means clustering classifies a given data set into an a-priori set of K clusters by minimizing an objective squared error function as shown in Eq.
65-1	9368-9370	As	_
65-2	9371-9373	an	_
65-3	9374-9386	unsupervised	_
65-4	9387-9395	learning	_
65-5	9396-9405	algorithm	_
65-6	9406-9407	,	_
65-7	9408-9415	K-means	_
65-8	9416-9426	clustering	_
65-9	9427-9437	classifies	_
65-10	9438-9439	a	_
65-11	9440-9445	given	_
65-12	9446-9450	data	_
65-13	9451-9454	set	_
65-14	9455-9459	into	_
65-15	9460-9462	an	_
65-16	9463-9471	a-priori	_
65-17	9472-9475	set	_
65-18	9476-9478	of	_
65-19	9479-9480	K	_
65-20	9481-9489	clusters	_
65-21	9490-9492	by	_
65-22	9493-9503	minimizing	_
65-23	9504-9506	an	_
65-24	9507-9516	objective	_
65-25	9517-9524	squared	_
65-26	9525-9530	error	_
65-27	9531-9539	function	_
65-28	9540-9542	as	_
65-29	9543-9548	shown	_
65-30	9549-9551	in	_
65-31	9552-9554	Eq	_
65-32	9555-9556	.	_

Text=(1): .where is a distance measure between a data point and the cluster center.
66-1	9557-9558	(	_
66-2	9559-9560	1	_
66-3	9561-9562	)	_
66-4	9563-9564	:	_
66-5	9565-9571	.where	_
66-6	9572-9574	is	_
66-7	9575-9576	a	_
66-8	9577-9585	distance	_
66-9	9586-9593	measure	_
66-10	9594-9601	between	_
66-11	9602-9603	a	_
66-12	9604-9608	data	_
66-13	9609-9614	point	_
66-14	9615-9618	and	_
66-15	9619-9622	the	_
66-16	9623-9630	cluster	_
66-17	9631-9637	center	_
66-18	9638-9639	.	_

Text=The algorithm was executed by: In order to determine the optimal number of clusters that best described the data set, we used the Bayesian Information Criterion (BIC), which is widely used for model identification in time series and linear regression: where n is the number of observations (=116); k is the number of class; RSS is the residual sum of squares from the K-means model.
67-1	9640-9643	The	_
67-2	9644-9653	algorithm	_
67-3	9654-9657	was	_
67-4	9658-9666	executed	_
67-5	9667-9669	by	_
67-6	9670-9671	:	_
67-7	9672-9674	In	_
67-8	9675-9680	order	_
67-9	9681-9683	to	_
67-10	9684-9693	determine	_
67-11	9694-9697	the	_
67-12	9698-9705	optimal	_
67-13	9706-9712	number	_
67-14	9713-9715	of	_
67-15	9716-9724	clusters	_
67-16	9725-9729	that	_
67-17	9730-9734	best	_
67-18	9735-9744	described	_
67-19	9745-9748	the	_
67-20	9749-9753	data	_
67-21	9754-9757	set	_
67-22	9758-9759	,	_
67-23	9760-9762	we	_
67-24	9763-9767	used	_
67-25	9768-9771	the	_
67-26	9772-9780	Bayesian	_
67-27	9781-9792	Information	_
67-28	9793-9802	Criterion	_
67-29	9803-9804	(	_
67-30	9805-9808	BIC	_
67-31	9809-9810	)	_
67-32	9811-9812	,	_
67-33	9813-9818	which	_
67-34	9819-9821	is	_
67-35	9822-9828	widely	_
67-36	9829-9833	used	_
67-37	9834-9837	for	_
67-38	9838-9843	model	_
67-39	9844-9858	identification	_
67-40	9859-9861	in	_
67-41	9862-9866	time	_
67-42	9867-9873	series	_
67-43	9874-9877	and	_
67-44	9878-9884	linear	_
67-45	9885-9895	regression	_
67-46	9896-9897	:	_
67-47	9898-9903	where	_
67-48	9904-9905	n	_
67-49	9906-9908	is	_
67-50	9909-9912	the	_
67-51	9913-9919	number	_
67-52	9920-9922	of	_
67-53	9923-9935	observations	_
67-54	9936-9937	(	_
67-55	9938-9942	=116	_
67-56	9943-9944	)	_
67-57	9945-9946	;	_
67-58	9947-9948	k	_
67-59	9949-9951	is	_
67-60	9952-9955	the	_
67-61	9956-9962	number	_
67-62	9963-9965	of	_
67-63	9966-9971	class	_
67-64	9972-9973	;	_
67-65	9974-9977	RSS	_
67-66	9978-9980	is	_
67-67	9981-9984	the	_
67-68	9985-9993	residual	_
67-69	9994-9997	sum	_
67-70	9998-10000	of	_
67-71	10001-10008	squares	_
67-72	10009-10013	from	_
67-73	10014-10017	the	_
67-74	10018-10025	K-means	_
67-75	10026-10031	model	_
67-76	10032-10033	.	_

Text=Given any two clustering number k ’ s, the one with lower BIC value was preferred.
68-1	10034-10039	Given	_
68-2	10040-10043	any	_
68-3	10044-10047	two	_
68-4	10048-10058	clustering	_
68-5	10059-10065	number	_
68-6	10066-10067	k	_
68-7	10068-10069	’	_
68-8	10070-10071	s	_
68-9	10072-10073	,	_
68-10	10074-10077	the	_
68-11	10078-10081	one	_
68-12	10082-10086	with	_
68-13	10087-10092	lower	_
68-14	10093-10096	BIC	_
68-15	10097-10102	value	_
68-16	10103-10106	was	_
68-17	10107-10116	preferred	_
68-18	10117-10118	.	_

Text=Furthermore, because the K-means algorithm is sensitive to the initial, randomly selected cluster centers, we repeated this algorithm 1,000 times to alleviate the effect of the initial conditions.
69-1	10119-10130	Furthermore	_
69-2	10131-10132	,	_
69-3	10133-10140	because	_
69-4	10141-10144	the	_
69-5	10145-10152	K-means	_
69-6	10153-10162	algorithm	_
69-7	10163-10165	is	_
69-8	10166-10175	sensitive	_
69-9	10176-10178	to	_
69-10	10179-10182	the	_
69-11	10183-10190	initial	_
69-12	10191-10192	,	_
69-13	10193-10201	randomly	_
69-14	10202-10210	selected	_
69-15	10211-10218	cluster	_
69-16	10219-10226	centers	_
69-17	10227-10228	,	_
69-18	10229-10231	we	_
69-19	10232-10240	repeated	_
69-20	10241-10245	this	_
69-21	10246-10255	algorithm	_
69-22	10256-10261	1,000	_
69-23	10262-10267	times	_
69-24	10268-10270	to	_
69-25	10271-10280	alleviate	_
69-26	10281-10284	the	_
69-27	10285-10291	effect	_
69-28	10292-10294	of	_
69-29	10295-10298	the	_
69-30	10299-10306	initial	_
69-31	10307-10317	conditions	_
69-32	10318-10319	.	_

Text=K was tested for values from 2 to 20.
70-1	10320-10321	K	_
70-2	10322-10325	was	_
70-3	10326-10332	tested	_
70-4	10333-10336	for	_
70-5	10337-10343	values	_
70-6	10344-10348	from	_
70-7	10349-10350	2	_
70-8	10351-10353	to	_
70-9	10354-10356	20	_
70-10	10357-10358	.	_

Text=For VS subregions as well as the whole VS, we computed the whole-brain connectivity maps each for CD and HC, and converted to z score maps.
71-1	10359-10362	For	_
71-2	10363-10365	VS	_
71-3	10366-10376	subregions	_
71-4	10377-10379	as	_
71-5	10380-10384	well	_
71-6	10385-10387	as	_
71-7	10388-10391	the	_
71-8	10392-10397	whole	_
71-9	10398-10400	VS	_
71-10	10401-10402	,	_
71-11	10403-10405	we	_
71-12	10406-10414	computed	_
71-13	10415-10418	the	_
71-14	10419-10430	whole-brain	_
71-15	10431-10443	connectivity	_
71-16	10444-10448	maps	_
71-17	10449-10453	each	_
71-18	10454-10457	for	_
71-19	10458-10460	CD	_
71-20	10461-10464	and	_
71-21	10465-10467	HC	_
71-22	10468-10469	,	_
71-23	10470-10473	and	_
71-24	10474-10483	converted	_
71-25	10484-10486	to	_
71-26	10487-10488	z	_
71-27	10489-10494	score	_
71-28	10495-10499	maps	_
71-29	10500-10501	.	_

Text=In second level analysis, we performed one-sample t test each on the Z maps of those seeds for CD and HC groups and two-sample t test with age as covariate comparing the two groups.
72-1	10502-10504	In	_
72-2	10505-10511	second	_
72-3	10512-10517	level	_
72-4	10518-10526	analysis	_
72-5	10527-10528	,	_
72-6	10529-10531	we	_
72-7	10532-10541	performed	_
72-8	10542-10552	one-sample	_
72-9	10553-10554	t	_
72-10	10555-10559	test	_
72-11	10560-10564	each	_
72-12	10565-10567	on	_
72-13	10568-10571	the	_
72-14	10572-10573	Z	_
72-15	10574-10578	maps	_
72-16	10579-10581	of	_
72-17	10582-10587	those	_
72-18	10588-10593	seeds	_
72-19	10594-10597	for	_
72-20	10598-10600	CD	_
72-21	10601-10604	and	_
72-22	10605-10607	HC	_
72-23	10608-10614	groups	_
72-24	10615-10618	and	_
72-25	10619-10629	two-sample	_
72-26	10630-10631	t	_
72-27	10632-10636	test	_
72-28	10637-10641	with	_
72-29	10642-10645	age	_
72-30	10646-10648	as	_
72-31	10649-10658	covariate	_
72-32	10659-10668	comparing	_
72-33	10669-10672	the	_
72-34	10673-10676	two	_
72-35	10677-10683	groups	_
72-36	10684-10685	.	_

Text=In addition, the VS and hypothalamus are reciprocally connected.
73-1	10686-10688	In	_
73-2	10689-10697	addition	_
73-3	10698-10699	,	_
73-4	10700-10703	the	_
73-5	10704-10706	VS	_
73-6	10707-10710	and	_
73-7	10711-10723	hypothalamus	_
73-8	10724-10727	are	_
73-9	10728-10740	reciprocally	_
73-10	10741-10750	connected	_
73-11	10751-10752	.	_

Text=Both the VS and hypothalamus receive projections from the dopaminergic midbrain and are implicated in processing of reward-related stimuli, including those associated with drugs of abuse.
74-1	10753-10757	Both	_
74-2	10758-10761	the	_
74-3	10762-10764	VS	_
74-4	10765-10768	and	_
74-5	10769-10781	hypothalamus	_
74-6	10782-10789	receive	_
74-7	10790-10801	projections	_
74-8	10802-10806	from	_
74-9	10807-10810	the	_
74-10	10811-10823	dopaminergic	_
74-11	10824-10832	midbrain	_
74-12	10833-10836	and	_
74-13	10837-10840	are	_
74-14	10841-10851	implicated	_
74-15	10852-10854	in	_
74-16	10855-10865	processing	_
74-17	10866-10868	of	_
74-18	10869-10883	reward-related	_
74-19	10884-10891	stimuli	_
74-20	10892-10893	,	_
74-21	10894-10903	including	_
74-22	10904-10909	those	_
74-23	10910-10920	associated	_
74-24	10921-10925	with	_
74-25	10926-10931	drugs	_
74-26	10932-10934	of	_
74-27	10935-10940	abuse	_
74-28	10941-10942	.	_

Text=Examining the VS hypothalamus connectivity may provide useful information as to how this understudied circuit is impacted by cocaine addiction.
75-1	10943-10952	Examining	_
75-2	10953-10956	the	_
75-3	10957-10959	VS	_
75-4	10960-10972	hypothalamus	_
75-5	10973-10985	connectivity	_
75-6	10986-10989	may	_
75-7	10990-10997	provide	_
75-8	10998-11004	useful	_
75-9	11005-11016	information	_
75-10	11017-11019	as	_
75-11	11020-11022	to	_
75-12	11023-11026	how	_
75-13	11027-11031	this	_
75-14	11032-11044	understudied	_
75-15	11045-11052	circuit	_
75-16	11053-11055	is	_
75-17	11056-11064	impacted	_
75-18	11065-11067	by	_
75-19	11068-11075	cocaine	_
75-20	11076-11085	addiction	_
75-21	11086-11087	.	_

Text=Thus, we also conducted a region of interest analysis, using small volume correction for a hypothalamus mask.
76-1	11088-11092	Thus	_
76-2	11093-11094	,	_
76-3	11095-11097	we	_
76-4	11098-11102	also	_
76-5	11103-11112	conducted	_
76-6	11113-11114	a	_
76-7	11115-11121	region	_
76-8	11122-11124	of	_
76-9	11125-11133	interest	_
76-10	11134-11142	analysis	_
76-11	11143-11144	,	_
76-12	11145-11150	using	_
76-13	11151-11156	small	_
76-14	11157-11163	volume	_
76-15	11164-11174	correction	_
76-16	11175-11178	for	_
76-17	11179-11180	a	_
76-18	11181-11193	hypothalamus	_
76-19	11194-11198	mask	_
76-20	11199-11200	.	_

